program 

  

Program Overview

02 September 2022
03 September 2022
World Ballroom
Time Title
09.00 - 11.00
Regional Joint Symposium: Thalassemia registry and regional perspectives

Chairs:  Antonio Almeida (Portugal) | Suradej Hongeng (Thailand)

•    Thalassemia registry in Thailand: from evidence to real-world practices
Speaker : Nattiya Teawtrakul (Thailand)
•    Thalassaemia in Bangladesh: Current Perspective
Speaker : Mujahida Rahman (Bangladesh)
•    Spectrum of Thalassemias and Hemoglobinopathies in Southern India
Speaker : Rakhee Kar (India)
•    Thalassemia Registry and regional perspectives: Malaysian Triumphs and Tribulations
Speaker : Veena Selvaratnam (Malaysia)
•    Stem cell transplant in thalassemia - where do we stand?
Speaker : Natasha Ali (Pakistan)
•    The Newborn Screening Program For Hemoglobin Disorders: The 8 Year Philippine Experience
Speaker : Reynaldo De Castro (Philippines)

•    Thalassemia in Sri Lanka; Thalassemia registry and preventive strategies
Speaker : Dr. Amila Amaresena (Sri Lanka) 
•    Panel Discussion
Speaker : All Speakers
11.00 - 11.15
Coffee Break / Exhibition
11.15 - 12.30
Session 4 : Multiple Myeloma

Chairs:   Adnan Hasan Masud (Bangladesh) | Gin Gin Gan (Malaysia)

•    Can novel triplets replace ASCT in Newly Diagnosed Multiple Myeloma (NDMM)?
Speaker : Roberto Mina (Italy)
•    Which BCMA therapy has the future: CAR-T or bispecifics?
Speaker : Niel van de Donk (The Netherlands)
•    Panel Discussion
Speaker : All Speakers
12.30 - 14.00
Lunch
12.45 - 13.45
Lunch Symposium II: AstraZeneca

Chair: Suporn Chuncharunee (Thailand)

•    Recent update of management of chronic lymphocytic leukemia (CLL)
Speaker : Lalita Norasetthada (Thailand)
13.45 - 15.30
Session 5 : MDS/MPN

Chairs:   Hara Prasad Pati (India) | Jesus A. Relos (Philippines) 

•    New targets: Can we achieve disease modification in MF?
Speaker : Jean Jacques Kiladjian (France)
•    From clonal hematopoiesis to myeloid malignancy – options for leukemia prevention?
Speaker : Kirsten Grønbæk (Denmark)
•    Immune system in MDS
Speaker : Antonio Almeida (Portugal)
•    Panel Discussion
Speaker : All Speakers
15.30 - 15.45
Coffee Break | Exhibition
15.45 - 17.00
Session 6 : Thrombosis

Chairs:   Marilou A. Abiera (Philippines)  |  Ponlapat Rojnuckarin (Thailand)

•    Overview - EHA Guidelines on Management of anti-thrombotic treatment in thrombocytopenic patients with cancer
Speaker : Hugo Ten Cate (The Netherlands)
•    Hormone-associated venous thromboembolism: How mechanistic insights and lessons from clinical studies shape the patients journey
Speaker : Per Morten Sandset (Norway)
•    Panel Discussion
Speaker : All Speakers
17.00 - 17.15
Closing ceremony